FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 124 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $486,000 | +109.5% | 13,000 | 0.0% | 0.00% | +100.0% |
| Q4 2020 | $232,000 | +68.1% | 13,000 | -43.0% | 0.00% | 0.0% |
| Q2 2019 | $138,000 | -96.6% | 22,800 | -92.0% | 0.00% | -95.8% |
| Q1 2019 | $4,019,000 | +4043.3% | 284,200 | +2393.0% | 0.02% | +2300.0% |
| Q4 2018 | $97,000 | -97.6% | 11,400 | -96.0% | 0.00% | -95.8% |
| Q3 2018 | $4,019,000 | +1718.6% | 284,200 | +1901.4% | 0.02% | +2300.0% |
| Q2 2018 | $221,000 | -95.0% | 14,200 | -94.8% | 0.00% | -96.7% |
| Q1 2018 | $4,456,000 | +19.8% | 274,200 | +110.1% | 0.03% | +3.4% |
| Q4 2017 | $3,721,000 | 0.0% | 130,500 | 0.0% | 0.03% | 0.0% |
| Q3 2017 | $3,721,000 | -9.6% | 130,500 | 0.0% | 0.03% | -12.1% |
| Q2 2017 | $4,116,000 | +672.2% | 130,500 | +800.0% | 0.03% | +560.0% |
| Q1 2017 | $533,000 | -32.4% | 14,500 | -7.6% | 0.01% | -37.5% |
| Q4 2016 | $788,000 | +4.8% | 15,700 | +8.3% | 0.01% | 0.0% |
| Q3 2016 | $752,000 | +24.5% | 14,500 | 0.0% | 0.01% | +14.3% |
| Q2 2016 | $604,000 | +28.5% | 14,500 | +22.9% | 0.01% | +16.7% |
| Q1 2016 | $470,000 | -13.8% | 11,800 | -9.9% | 0.01% | 0.0% |
| Q4 2015 | $545,000 | +173.9% | 13,100 | +1.6% | 0.01% | +200.0% |
| Q3 2015 | $199,000 | -34.3% | 12,900 | +5.7% | 0.00% | -50.0% |
| Q2 2015 | $303,000 | +13.5% | 12,200 | +4.3% | 0.00% | +33.3% |
| Q1 2015 | $267,000 | – | 11,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|